These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20381556

  • 21. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.
    Vaccine; 2008 Mar 04; 26(10):1375-86. PubMed ID: 18272264
    [Abstract] [Full Text] [Related]

  • 22. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins.
    Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Fujiwara H, Hamaoka T, Mayumi T.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):793-7. PubMed ID: 9398647
    [Abstract] [Full Text] [Related]

  • 23. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST, Olsen CL, Franzyk H, Wørzner K, Korsholm KS, Rades T, Andersen P, Foged C, Christensen D.
    Eur J Pharm Biopharm; 2019 Jul 26; 140():29-39. PubMed ID: 31055066
    [Abstract] [Full Text] [Related]

  • 24. Mannosylated liposomes for targeted vaccines delivery.
    Vyas SP, Goyal AK, Khatri K.
    Methods Mol Biol; 2010 Jul 26; 605():177-88. PubMed ID: 20072881
    [Abstract] [Full Text] [Related]

  • 25. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr 26; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 26. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.
    van den Berg JH, Oosterhuis K, Hennink WE, Storm G, van der Aa LJ, Engbersen JF, Haanen JB, Beijnen JH, Schumacher TN, Nuijen B.
    J Control Release; 2010 Jan 25; 141(2):234-40. PubMed ID: 19751778
    [Abstract] [Full Text] [Related]

  • 27. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K, Khanna N, Chattree V, Pal PC, Haq W, Rao DN.
    Int Immunopharmacol; 2003 Nov 25; 3(12):1589-600. PubMed ID: 14555284
    [Abstract] [Full Text] [Related]

  • 28. CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.
    Christensen D, Foged C, Rosenkrands I, Lundberg CV, Andersen P, Agger EM, Nielsen HM.
    Int J Pharm; 2010 May 05; 390(1):19-24. PubMed ID: 19879346
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
    Even-Or O, Samira S, Rochlin E, Balasingam S, Mann AJ, Lambkin-Williams R, Spira J, Goldwaser I, Ellis R, Barenholz Y.
    Vaccine; 2010 Sep 07; 28(39):6527-41. PubMed ID: 20412874
    [Abstract] [Full Text] [Related]

  • 30. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y, Wakita D, Chamoto K, Narita Y, Tsuji T, Takeshima T, Gyobu H, Kawarada Y, Kondo S, Akira S, Katoh H, Ikeda H, Nishimura T.
    Cancer Res; 2004 Dec 01; 64(23):8754-60. PubMed ID: 15574787
    [Abstract] [Full Text] [Related]

  • 31. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
    Mazumder S, Ravindran R, Banerjee A, Ali N.
    Vaccine; 2007 Dec 17; 25(52):8771-81. PubMed ID: 18031874
    [Abstract] [Full Text] [Related]

  • 32. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
    Zigterman GJ, Snippe H, Jansze M, Willers JM.
    J Immunol; 1987 Jan 01; 138(1):220-5. PubMed ID: 3782798
    [Abstract] [Full Text] [Related]

  • 33. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y, Ma Y, Wang C, Hai L, Yan C, Zhang Y, Liu F, Cai L.
    J Control Release; 2012 Apr 10; 159(1):135-42. PubMed ID: 22226776
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    Jérôme V, Graser A, Müller R, Kontermann RE, Konur A.
    J Immunother; 2006 Apr 10; 29(3):294-305. PubMed ID: 16699372
    [Abstract] [Full Text] [Related]

  • 35. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S, Young K, Wilson R, Rizwan S, Kemp R, Rades T, Hook S.
    J Liposome Res; 2012 Sep 10; 22(3):193-204. PubMed ID: 22188610
    [Abstract] [Full Text] [Related]

  • 36. Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response.
    Nguyen CL, Bui JT, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE.
    J Immunother; 2001 Sep 10; 24(5):420-9. PubMed ID: 11696697
    [Abstract] [Full Text] [Related]

  • 37. Cationic liposomes as vaccine adjuvants.
    Christensen D, Korsholm KS, Andersen P, Agger EM.
    Expert Rev Vaccines; 2011 Apr 10; 10(4):513-21. PubMed ID: 21506648
    [Abstract] [Full Text] [Related]

  • 38. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
    Yoshikawa T, Imazu S, Gao JQ, Hayashi K, Tsuda Y, Shimokawa M, Sugita T, Niwa T, Oda A, Akashi M, Tsutsumi Y, Mayumi T, Nakagawa S.
    Biochem Biophys Res Commun; 2004 Dec 10; 325(2):500-5. PubMed ID: 15530420
    [Abstract] [Full Text] [Related]

  • 39. [Application of surface-linked liposomal antigens for the development of vaccines].
    Uchida T, Taneichi M.
    Nihon Rinsho; 2008 Oct 10; 66(10):1894-902. PubMed ID: 18939487
    [Abstract] [Full Text] [Related]

  • 40. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.
    Hussain MJ, Wilkinson A, Bramwell VW, Christensen D, Perrie Y.
    J Pharm Pharmacol; 2014 Mar 10; 66(3):358-66. PubMed ID: 24251796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.